Header Image - Gluten Light

Tag Archives

3 Articles

In-Depth: “Oxidative Stress: What It Is, Why It Arises, What It Causes, How to Reduce It”

by luciano

✅ RELATED ARTICLE 1
Mitochondria and Oxidative Stress
Highlight
Mitochondria are the main source of ROS in the body and at the same time one of the primary targets of oxidative damage.

Their efficiency largely determines the level of cellular oxidative stress.

What mitochondria do
Produce ATP via oxidative phosphorylation
Regulate apoptosis
Participate in cellular signaling
Regulate nutrient metabolism
During energy production, a small fraction of electrons escapes from the respiratory chain, forming superoxide.

Why mitochondria produce ROS
In the electron transport chain:
O₂ + electron → O₂•⁻

This is a physiological and unavoidable event.

BOX — Physiological production
A moderate production of mitochondrial ROS is necessary for:

adaptive signaling
Nrf2 activation
mitochondrial biogenesis
What is mitochondrial dysfunction
A condition in which:

ATP production decreases
electron leakage increases
ROS production increases
A vicious cycle is created:

Inefficient mitochondrion → more ROS → mitochondrial damage → even less efficient mitochondrion

Factors that damage mitochondria
chronic hyperglycemia
excess oxidized fats
inflammation
toxins
micronutrient deficiencies
sleep deprivation
Mitochondria and chronic diseases
Mitochondrial dysfunction observed in:

type 2 diabetes
cardiovascular disease
neurodegeneration
sarcopenia
aging
How to improve mitochondrial function
Nutrition

adequate protein intake
micronutrients (B vitamins, iron, copper, magnesium)
polyphenols
Physical activity

aerobic exercise
resistance training
Sleep

regularity
7–9 hours
Stress

reduction of chronic load
BOX — Key concept
Oxidative stress is not reduced by “turning off ROS.”
It is reduced by making mitochondria more efficient.

Conclusion
The mitochondrion is the central hub of redox metabolism.
Protecting mitochondrial function means acting upstream on oxidative stress.

✅ RELATED ARTICLE 2
Circadian Rhythm and Oxidative Stress
Highlight
The circadian rhythm coordinates the expression of genes involved in metabolism, energy production, and antioxidant systems.
When this timing system is altered, ROS production increases and the capacity to neutralize them decreases, promoting chronic oxidative stress.

What is the circadian rhythm
A biological timing system of about 24 hours that regulates:

sleep–wake cycle
hormone secretion
energy metabolism
body temperature
cellular repair activity
The main control center is the suprachiasmatic nucleus of the hypothalamus, mainly synchronized by light.

Central and peripheral clocks
There are:

one central clock (brain)
peripheral clocks (liver, muscle, pancreas, adipose tissue, heart)
These clocks regulate the temporal expression of thousands of metabolic genes.

BOX — Key concept
Not only what you do, but also when you do it influences redox metabolism.

Link between circadian rhythm and antioxidant systems
Many antioxidant enzymes show circadian oscillations:

superoxide dismutase (SOD)
catalase
glutathione peroxidase
Glutathione synthesis also follows a daily rhythm.
If rhythm is disturbed, these oscillations flatten → lower antioxidant defenses.

Circadian rhythm and mitochondria
The biological clock regulates:

mitochondrial biogenesis
fusion/fission dynamics
respiratory chain efficiency
Circadian misalignment → less efficient mitochondria → greater electron leakage → more ROS.

What disrupts circadian rhythm
evening artificial light
nighttime screen exposure
shift work
insufficient sleep
irregular or nighttime meals
social jet lag
Biological effects of misalignment
Chronic misalignment causes:

increased ROS production
reduced antioxidant activity
increased inflammation
altered glucose and lipid metabolism
BOX — Simplified mechanism
Altered rhythm → inefficient mitochondria → ↑ ROS
Altered rhythm → ↓ antioxidant enzymes
Result: oxidative stress

Circadian rhythm and chronic diseases
Associated with higher risk of:

obesity
type 2 diabetes
metabolic syndrome
cardiovascular disease
cognitive decline
Partly through increased systemic oxidative stress.

Sleep: the main redox “reset”
During sleep:

brain metabolism decreases
antioxidant activity increases
DNA repair systems activate
mitochondrial efficiency improves
Sleep deprivation → measurable increase in oxidative stress markers after only a few nights.

Meal timing and oxidative stress
Eating at biologically inappropriate times:

worsens glycemic control
increases mitochondrial ROS production
promotes lipotoxicity
An eating window aligned with the light–dark cycle improves redox balance.

How to protect circadian rhythm
Light

natural light in the morning
reduced blue light in the evening
Sleep

regular schedule
adequate duration
Meals

consistent timing
avoid large nighttime meals
Physical activity

preferably during daytime
BOX — Key concept
Without a functional circadian rhythm, even a perfect diet and good supplements have limited effectiveness on oxidative stress.

Integration with other pillars
Circadian rhythm acts in synergy with:

mitochondrial function
exercise
stress management
Protecting rhythm is a primary lever in oxidative stress prevention.

Conclusion
The circadian rhythm is a fundamental regulator of redox balance.
Its disruption promotes both increased ROS production and reduced antioxidant defenses, creating conditions for chronic oxidative stress.
Preserving the light–dark rhythm is one of the most powerful and underestimated interventions for cellular health.

✅ RELATED ARTICLE 3
Exercise, Hormesis, and Nrf2: Why Movement Reduces Oxidative Stress
Highlight
Exercise transiently increases ROS production, but this controlled stimulus activates powerful adaptive mechanisms that enhance endogenous antioxidant defenses.
This phenomenon is known as hormesis and is largely mediated by the transcription factor Nrf2.

The exercise paradox
During physical activity:

oxygen consumption increases
mitochondrial electron flux increases
ROS production temporarily increases
Yet, in the long term, regularly trained individuals show lower basal oxidative stress.

BOX — Apparent paradox
Exercise produces ROS, but training reduces chronic oxidative stress.

What is hormesis
Hormesis is a biological principle whereby:
A small stress activates protective adaptations that make the organism more resistant.

In exercise:
ROS transients → signal → adaptation → increased antioxidant capacity

Nrf2: the master regulator
Nrf2 (Nuclear factor erythroid 2–related factor 2) is a transcription factor that:

senses oxidative stress signals
migrates to the nucleus
activates antioxidant gene expression
Genes regulated by Nrf2 include:

glutathione synthase
glutathione peroxidase
superoxide dismutase
catalase
phase II detoxification enzymes
BOX — Key concept
Nrf2 does not neutralize ROS directly.
It increases the cell’s ability to defend itself.

What happens with regular training
Over time:

glutathione content increases
antioxidant enzymes increase
mitochondrial efficiency improves
basal ROS production decreases
Result: greater redox resilience.

Types of exercise and redox response
Aerobic

brisk walking
moderate running
cycling
Promotes:
mitochondrial biogenesis
Nrf2 activation
Strength

weights
bodyweight training
Promotes:
increased muscle mass
improved glucose metabolism
lower resting ROS production
HIIT

strong adaptive stimulus
useful if properly dosed
When exercise becomes harmful
Excess volume or intensity without recovery:

persistently elevated ROS
reduced immune function
increased inflammation
BOX — Optimal zone
Too little exercise → oxidative stress
Too much exercise → oxidative stress
Moderate dose → protective adaptation

Antioxidants and exercise: caution
High-dose vitamin C and E supplementation:

may blunt Nrf2 activation
may reduce some metabolic benefits of training
Integration with lifestyle
Exercise protection is maximal when combined with:

adequate sleep
balanced nutrition
stress management
Exercise as “medicine”
Physical activity:

reduces cardiovascular risk
improves insulin sensitivity
protects the brain
slows biological aging
Largely through improved redox balance.

BOX — Final key concept
Exercise does not reduce oxidative stress by eliminating ROS,
but by making the organism better able to handle them.

Conclusion
Physical exercise is one of the most powerful physiological tools for controlling oxidative stress.
Through transient ROS increases, it activates Nrf2 and triggers adaptations that strengthen endogenous antioxidant defenses, improving long-term cellular health.

✅ RELATED ARTICLE 4
Low-Grade Chronic Inflammation and Oxidative Stress
Highlight
Low-grade chronic inflammation is a persistent state of mild immune activation, often asymptomatic, that contributes to the development of many chronic diseases.
It is tightly intertwined with oxidative stress through a mutually amplifying circuit.

What is low-grade chronic inflammation
Unlike acute inflammation (rapid and resolving), it is:

persistent
systemic
low intensity
It does not cause obvious clinical signs but progressively alters tissue physiology.

Difference between acute and chronic inflammation
Acute inflammation

protective response
short duration
promotes healing
Low-grade chronic inflammation

continuous activation
lack of resolution
promotes tissue damage
BOX — Key concept
The problem is not inflammation itself, but its persistence.

Link with oxidative stress
Oxidative stress and inflammation form a bidirectional loop:

ROS activate inflammatory pathways
inflammatory cells produce ROS
BOX — Simplified circuit
ROS → cellular damage → inflammation → ROS production → further damage

Molecular mechanism
ROS activate transcription factors such as:

NF-κB
AP-1
These induce production of:

IL-6
TNF-α
other pro-inflammatory cytokines
Cytokines in turn increase:

oxidase activity
mitochondrial ROS production
Oxidative damage as primary event
Molecular damage caused by ROS can occur:

in absence of immune cells
directly to DNA, lipids, proteins
Inflammation represents a secondary response to damage.

BOX — Crucial point
Oxidative stress can initiate damage.
Inflammation maintains it.

Chronic inflammation and metabolism
Low-grade inflammation:

reduces insulin sensitivity
promotes dysfunctional lipolysis
increases ROS production
Explaining links with:

type 2 diabetes
metabolic syndrome
visceral obesity
Chronic inflammation and target organs
Involved in:

atherosclerosis
fatty liver
neurodegeneration
sarcopenia
Main factors promoting chronic inflammation
caloric excess
ultra-processed diet
sedentary lifestyle
sleep deprivation
psychological stress
gut dysbiosis
How to reduce chronic inflammation
Diet

high nutrient density
fiber
unsaturated fats
Physical activity

regular
Sleep

7–9 hours
Stress management

relaxation practices
BOX — Key concept
Reducing chronic inflammation also reduces oxidative stress.

Integration with other pillars
Inflammation is modulated by:

mitochondrial function
circadian rhythm
physical exercise
No single intervention is sufficient.

Conclusion
Low-grade chronic inflammation and oxidative stress form an integrated system of biological damage amplification.
Interrupting this circuit requires a systemic approach acting on metabolism, lifestyle, and neuroendocrine regulation.

✅ RELATED ARTICLE 5
Biomarkers of Oxidative Stress: What to Measure and How to Interpret
Highlight
Oxidative stress cannot be evaluated with a single test.
A clinically meaningful assessment requires integration of biomarkers of oxidative damage, inflammation, antioxidant capacity, and metabolic context.

Why there is no “perfect marker”
Oxidative stress is a dynamic process involving:

ROS production
molecular damage
antioxidant response
repair
Each biomarker observes only one part.

BOX — Key concept
A panel is more informative than a single value.

1) Direct biomarkers of oxidative damage
F2-isoprostanes

Derived from non-enzymatic lipid peroxidation
Considered gold standard for lipid oxidative damage
Sample: plasma or urine
Interpretation:
High → high lipid oxidative stress
Malondialdehyde (MDA)

Lipid peroxidation product
More variable than isoprostanes
Interpretation:
Useful as orientative indicator
8-OHdG (8-hydroxy-2’-deoxyguanosine)

Marker of oxidative DNA damage
Urine or blood
Interpretation:
High → increased DNA oxidation
2) Antioxidant capacity biomarkers
Reduced glutathione (GSH) and GSH/GSSG ratio

Central redox parameter
Interpretation:
High ratio → good balance
Low ratio → oxidative stress
Total antioxidant capacity (TAC)

Global estimate of ROS-neutralizing ability
Low specificity
Interpretation:
Useful as complement
3) Inflammation-related biomarkers
hs-CRP

Integrated marker of systemic inflammation
Indicative values:
<1 mg/L → low CV risk
1–3 mg/L → intermediate risk
3 mg/L → high risk
IL-6, TNF-α

Pro-inflammatory cytokines
Mainly specialist use
4) Indirect metabolic biomarkers
Glucose, insulin, HOMA-IR
Triglycerides, oxLDL
Ferritin
BOX — Key concept
Metabolic alterations are often the main source of chronic oxidative stress.

5) Advanced mitochondrial biomarkers
Resting lactate
Lactate/pyruvate ratio
CoQ10
Useful in specialist settings.

6) Minimal practical panel
hs-CRP
F2-isoprostanes or MDA
8-OHdG
GSH/GSSG
Glucose + insulin
7) Integrated interpretation example
hs-CRP ↑
MDA ↑
GSH/GSSG ↓

Indicates:

active oxidative stress
associated inflammation
reduced defenses
8) Temporal changes after intervention
Improve first:

GSH/GSSG
hs-CRP
Later:

MDA / F2-isoprostanes
Slowest:

8-OHdG
BOX — Typical sequence
Protection rises → damage falls → DNA improves

9) Common errors
Relying on one marker
Using TAC alone
Interpreting without clinical context
Conclusion
Assessment of oxidative stress requires a multiparametric approach.
Integrating damage, antioxidant capacity, inflammation, and metabolism allows a biologically coherent reading of redox status.

✅ RELATED ARTICLE 6
Antioxidant Supplements: When They Are Truly Needed
Highlight
Antioxidant supplements are not a universal solution to oxidative stress.
In many cases, indiscriminate use is useless or potentially counterproductive.
The most effective strategy remains strengthening endogenous antioxidant defenses.

Why “more antioxidants = less ROS” is wrong
ROS:

are not only toxic byproducts
have essential physiological functions
Indiscriminately eliminating ROS can:

interfere with signaling
reduce beneficial adaptations
BOX — Key concept
The goal is not to suppress ROS, but to restore redox balance.

What dietary antioxidants really do
Dietary antioxidants:

partially buffer ROS
mainly activate signaling pathways (e.g., Nrf2)
Many polyphenols act more as adaptive signals than direct scavengers.

Evidence on high-dose supplements
Chronic high-dose vitamin C and E:

may reduce exercise metabolic benefits
may blunt Nrf2 activation
When supplementation may be useful
Documented deficiencies
vitamin C
vitamin E
selenium
zinc
Increased demand
high stress
infections
toxin exposure
recovery phases
Specific clinical conditions
malabsorption
selected chronic diseases
Types of integrative approach
Direct antioxidants

vitamin C
vitamin E
Glutathione precursors

N-acetylcysteine
glycine
Mitochondrial modulators

CoQ10
alpha-lipoic acid
BOX — Preferred strategy
Better to provide substrates and signals to produce endogenous antioxidants than large doses of external scavengers.

Risks of abuse
reduced training adaptations
possible increased mortality in some populations
false sense of security delaying lifestyle change
Correct intervention sequence
Sleep
Nutrition
Physical activity
Stress management
Only then: targeted supplementation
Supplementation and personalization
Good supplementation:

is temporary
is biomarker-based
is re-evaluated
Conclusion
Antioxidant supplements do not replace a healthy lifestyle.
They may play a targeted role in selected contexts, but the most effective protection against oxidative stress comes from strengthening the body’s intrinsic capacity.

 

 

 

Human Microbiota and Toxin Metabolism

by luciano

Abstract
The human gut microbiota is a complex ecosystem of microorganisms that plays a central role in digestion, immune function, metabolic regulation, and the handling of dietary and environmental toxins. Through the fermentation of non-digestible carbohydrates and fibers, gut bacteria produce short-chain fatty acids (SCFAs) such as butyrate, acetate, and propionate, which act as key metabolic mediators between the microbiota and the host. These metabolites serve as essential energy substrates for intestinal epithelial cells, support gut barrier integrity, and modulate inflammatory responses and systemic metabolism.
In addition to carbohydrate fermentation, the gut microbiota is involved in the biotransformation of xenobiotics, including environmental toxins, drugs, and food-derived compounds, influencing their bioavailability and toxicity. Conversely, exposure to antibiotics, pollutants, alcohol, and ultra-processed foods can disrupt microbial balance, leading to dysbiosis, increased intestinal permeability, inflammation, and metabolic disorders.
This article explores the bidirectional interactions between the gut microbiota and toxins, the different types of bacterial fermentation (saccharolytic versus proteolytic), and the concept of energetic symbiosis between microbes and the human host. Understanding these mechanisms highlights the crucial role of diet—particularly dietary fiber—in maintaining microbiota functionality, metabolic health, and resilience against toxic and inflammatory challenges.

Keywords
Gut microbiota; Short-chain fatty acids (SCFAs); Dietary fiber; Butyrate; Fermentation; Metabolic health; Inflammation; Gut barrier; Dysbiosis; Toxin metabolism; Gut–liver axis; Energetic symbiosis
1) Human microbiota: definition and role
Definition
The human microbiota is the collection of microorganisms (bacteria, viruses, and fungi) that live on and within the human body, particularly in the gut, and contribute to critical metabolic and immune functions. (Nature)
Main functions
Digestion and fermentation of non-digestible fibers → production of short-chain fatty acids (SCFAs), such as butyrate. (MDPI)
Modulation of energy and glucose metabolism. (Nature)
Maintenance of the immune barrier and protection against pathogens. (Nature)
Involvement in the gut–liver and gut–brain axes. (Atti dell’Accademia Lancisiana)

2) Interactions between the microbiota and toxins
2A – Microbiota → toxins/metabolites
The microbiota:
Ferments dietary fibers [1], producing beneficial metabolites (SCFAs). (MDPI)
Metabolizes xenobiotics (environmental toxins, drugs, additives), influencing their chemical form and toxicity. (MDPI)
Contributes to the intestinal barrier, limiting the absorption of harmful substances. (Atti dell’Accademia Lancisiana)
Recent research:
1. Fan & Pedersen (2020): link the gut microbiota to the metabolism of food-derived compounds and toxins in humans. (Nature)
2. Tu et al. (2020): review on the microbiome and environmental toxicity (concept of gut microbiome toxicity). (MDPI)

2B – Toxins → microbiota
Some agents negatively impact the microbiota:
Antibiotics → intestinal dysbiosis
Pesticides/heavy metals → alteration of microbial diversity
Alcohol and ultra-processed foods → emerging negative effects
Evidence examples:
Environmental and dietary factors can alter microbial balance and increase inflammation. (ScienceDirect)

2C – Effects of dysbiosis
Dysbiosis (microbiota imbalance) may lead to:
Intestinal inflammation
Increased intestinal permeability (leaky gut)
Metabolic disorders (obesity, insulin resistance)
Recent scientific evidence:
Reviews linking microbiota composition to metabolism and human health. (Nature)

3) Factors influencing the microbiota
Factor
Effect
High-fiber diet
↑ diversity and SCFA production (MDPI)
Polyphenols (fruit/vegetables, tea, wine, olive oil)
Positive modulation of the microbial community
Antibiotics
↓ biodiversity, ↑ dysbiosis
Alcohol
May damage the mucosa and promote permeability
Ultra-processed foods
Associated with dysbiosis (mechanisms still under investigation)
Key research:
1. Charnock & Telle-Hansen (2020): effects of fiber on the microbiota and metabolic health. (MDPI)
2. PubMed reviews (2023–2024): fiber and microbiota modulation with clinical implications in metabolic diseases. (PubMed)

4) Toxin elimination: integrated physiological pathways
Liver
Phase I: structural modification of toxins (oxidation)
Phase II: conjugation → increased solubility
Elimination via bile → intestine
The microbiota may modify these metabolites and influence their recirculation
Kidneys
Filter the blood
Eliminate water-soluble toxins through urine
Intestine + microbiota
Excretion of toxins via feces
Physical and metabolic barrier against the absorption of harmful compounds
Lungs and skin
Elimination of CO₂ and volatile compounds
Minor role in the detoxification of more complex molecules

5) Integrative key concepts
SCFAs and health
Products of bacterial fiber fermentation (e.g., butyrate) not only provide substrates for intestinal cells but also modulate inflammation and systemic metabolism. (MDPI)
Microbiota and the gut–liver axis
Microbial metabolites influence hepatic metabolism, with potential effects on toxin handling and lipid metabolism. (Nature)
Diet and metabolic diseases
Microbiota changes associated with low fiber intake are linked to obesity and type 2 diabetes. (PubMed)

Mini-summary
1. The gut microbiota is an ecosystem of microorganisms that supports digestion, immunity, and metabolism; its alteration (dysbiosis) is associated with metabolic diseases. (Nature)
2. Non-digestible dietary fibers are fermented by gut microbes into beneficial compounds (SCFAs). (MDPI)
3. Microbiota and toxins influence each other: the microbiota can degrade or transform xenobiotics, while substances such as antibiotics and pollutants can alter microbial composition. (MDPI)
4. The body eliminates toxins through the liver, kidneys, intestine (with microbiota involvement), lungs, and skin.

Low-grade inflammation and the brain

by luciano

“What is inflammation?
We usually talk about “inflammation” in relation to infections and injuries. When the body is infected, the immune cells recognize the ‘non-self’ molecules and produce inflammatory factors, called “cytokines”, to coordinate the fight against the infection. Cytokines signal other immune cells and bring them to the site of infection. Inflammation is clinically assessed by measuring cytokine concentrations or other inflammatory markers in the blood and is used as a sign of infection.
What is low-grade inflammation?
It is a question that remains hard to answer. Low-grade inflammation is usually defined as “the chronic production, but a low-grade state, of inflammatory factors”. Conditions characterized by low-grade inflammation are for instance obesity (1), depression (2) or chronic pain (3). Low-grade inflammation does not come from an infection but several physiological mechanisms are involved. Concentrations of inflammatory factors in these conditions are overall slightly higher than in healthy populations, but still remain in the healthy ranges. It is therefore hard to determine whether a specific patient exhibits “low-grade inflammation” but it can be better defined at the level of a group of patients.
Inflammation and the brain
When we are sick, we often want to sleep, have reduced appetite, prefer to stay home alone, have difficulty concentrating and can be a bit moody. All these feelings and behaviors are induced by cytokines! Indeed, in addition to coordinating the fight against infection in the periphery of the body, cytokines also act in the brain and induce behavioral changes (4). All these behavioral changes are adaptive, with the purpose of limiting the spread of the infection and allowing the body to spare energy in order to fight the infection instead of, say, going out partying with friends.
However, the behavioral effects of cytokines are not always beneficial. When the cytokine signal is too strong or lasts a long time, such as in cancer patients during treatment with cytokines, these effects can become maladaptive and lead to more chronic and pathological behavioral alterations, such as depression (5). Inflammation is therefore one hypothesized contributor to depression (4). One critical difference between infection or cancer therapy and most cases of depression is, however, the level of production of inflammatory factors. Cytokine levels are high during immunotherapy, i.e., “inflammation”, while depression is characterized by a state of “low-grade inflammation”.
The proportion of subjects who suffer from depression is higher in conditions characterized by low-grade inflammation than in the general population. For instance, 20 to 30% of obese individuals suffer from depression while the prevalence in the general population is of 5-10% (6). While psychological factors are highly likely to be involved, we and others investigate the possibility that low-grade inflammation contributes to this psychiatric vulnerability (7). We have notably shown that low-grade inflammation is associated with behavioral changes in obese individuals, such as fatigue (8) or altered cognitive functions (9). One interpretation of this relationship is that the production of inflammatory factors at a low-grade state may be sufficient to induce behavioral alterations and therefore could be one factor participating to the vulnerability to depression.
Low-grade inflammation and chronic pain
The association between low-grade inflammation and behavioral alterations has caused the team of the Behavioral Medicine Pain Treatment Service at the Karolinska University Hospital in Stockholm (Sweden) to wonder whether low-grade inflammation could modulate the efficacy of behavioral treatments for chronic pain. Cognitive and behavioral strategies are indeed the targets of behavioral treatments for chronic pain and low-grade inflammation could prevent the effects of such treatments.
In collaboration with this group, we showed that treatment outcomes were improved in patients with chronic pain and low levels of inflammatory factors while patients with “low-grade inflammation”, i.e., with higher levels of inflammatory markers but still in the healthy range, exhibited less improvement (10).
Although this study was only exploratory, the findings suggest that low-grade inflammation may promote a state of resistance to behavioral treatment for chronic pain and give a potential explanation regarding non-responder patients.
About Julie Lasselin
Dr Julie Lasselin is a “psychoneuroimmunologist”, conducting research assessing the relationships between the brain and the immune system. She got her Ph.D. in 2012 in NutriNeuro in Bordeaux, France. She then has been working as a post-doc at the Department of Clinical Neuroscience (Psychology Division), Karolinska Institute and at the Stress Research Institute, Stockholm University in Stockholm, Sweden. Julie is currently a post-doc in the Institute of Medical Psychology and Behavioral Immunobiology in Essen, Germany and is affiliated to the Karolinska Institute and Stockholm University. Her research focuses on the contribution of inflammation on the development of neuropsychiatric symptoms in vulnerable populations, such as patients suffering from obesity and type 2 diabetes. She carries out both clinical observational studies and experimental studies using the model of administration of lipopolysaccharide (a component of bacterial shell) in humans. She also assesses more specifically the role of inflammation in fatigue and motivational changes, two symptoms that are highly sensitive to inflammation and may explain the psychiatric vulnerability of obese patients.”
References
1. Wellen, K.E. and G.S. Hotamisligil, Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 2003. 112:1785-8.
2. Dantzer, R., Depression and inflammation: an intricate relationship. Biol Psychiatry, 2012. 71: p. 4-5.
3. Parkitny, L., et al., Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology, 2013. 80:106-17.
4. Dantzer, R., et al., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 2008. 9:46-56.
5. Capuron, L. and A.H. Miller, Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther, 2011. 130:226-38.
6. Evans, D.L., et al., Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry, 2005. 58:175-89.
7. Capuron, L., J. Lasselin, and N. Castanon, Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology, 2016 (in press).
8. Lasselin, J., et al., Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav Immun, 2012. 26:1211-9.
9. Lasselin, J., et al., Low-grade inflammation is a major contributor of impaired attentional set shifting in obese subjects. Brain Behav Immun, 2016. 58:63-68.
10. Lasselin, J., et al., Low-grade inflammation may moderate the effect of behavioral treatment for chronic pain in adults. J Behav Med, 2016. 39:916-24.